From What’s Hot in Boston Biotech: The Photos:

What's Hot in Boston Biotech
What’s Hot in Boston Biotech

Steve Paul acknowledged that gene therapy, despite its progress, is still in its early days. So is his company, Voyager Therapeutics—which is 14 months old yet is now poised for an IPO, as we wrote yesterday.